Presentations 2026
Conference on Retrovirus and Opportunistic Infections (CROI 2026), Denver, Colorado, USA, 22-25 February 2026
Evaluating the impact of integrase inhibitors (INSTIs) on cardiovascular disease (CVD) presented by Bastian Neesgaard on behalf of the RESPOND study group. Poster
International Workshop on HIV and Hepatitis Observational Databases, Thessaloniki, Greece, 26-29 March 2026
Poster presentation:
Risk of fracture with contemporary antiretrovirals within the RESPOND Consortium presented by Bastian Neesgaard on behalf of the RESPOND study group. Poster
AIDS 2026, the 26th International AIDS Conference, Rio de Janeiro, Brazil, 26-31 July 2026.
Poster presentations:
Risk of fracture with contemporary antiretrovirals within the RESPOND Consortium presented by Bastian Neesgaard on behalf of the RESPOND study group. Poster
Association between integrase inhibitors (INSTIs) and tenofovir alafenamide (TAF) and moderate chronic kidney disease (CKD) in the RESPOND HIV cohort collaboration presented by Lauren Greenberg on behalf of the RESPOND study group. Poster
European Society of Cardiology Congress 2026, Munich, Germany, 28-31 August 2026
Poster presentation:
Sex disparities of myocardial infarction in individuals with HIV across Europe and Australia: a multinational cohort study will be presented by Nadine Jaschinski on behalf of the RESPOND study group.